D
Dio Corp
KOSDAQ:039840
Dio Corp
KOSDAQ:039840
Price:
16 800
KRW
0.3%
Market Cap:
₩241.6B
Relative Value
The Relative Value of one Dio Corp stock under the Base Case scenario is 25 019.99 KRW. Compared to the current market price of 16 800 KRW, Dio Corp is Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
25 019.99
KRW
Undervaluation 33%
D
Multiples Across Competitors
Competitors Multiples
Dio Corp Competitors
Dio Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
D
|
Dio Corp
KOSDAQ:039840
|
224.9B KRW | 1.4 | 37 | 14.6 | 34.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
191.5B USD | 4.3 | 29.3 | 16.8 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175B USD | 17.4 | 61.3 | 46.5 | 57.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
132.3B USD | 5.3 | 40.7 | 20.8 | 25.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 3.2 | 24.8 | 13.6 | 19.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.3B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.2B EUR | 1.9 | 20.9 | 11.6 | 16.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.4B USD | 8.2 | 46.1 | 25.4 | 27.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.9B USD | 11.1 | 45.2 | 32.1 | 35.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.5B USD | 2.1 | 26.4 | 10.3 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
35B USD | 6.5 | 23.5 | 16.6 | 18.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
